INTERNATIONAL PHYTOMEDICINES INSTITUTE
"Health and Wealth:
Global Health and Economic Development from Medicinal Plants"
WORLD-LEADING INTERNATIONAL PHYTOMEDICINES AND MEDICAL CANNABIS COLLABORATION INITIATIVE
Catalyzing high impact collaborations on evidence-based phytomedicines for global health and economic development working with partners from industry, academic institutions, policy makers, and millions of stakeholders around the world
Consultation on evidence-based phytomedicines and OUTREACH: Opportunities with, industry partners and stakeholders across the world including during the global health catalyst summits
Leading -edge research for superior product quality assurance and evidence-based phytomedicines
Providing world-class education and training on evidence-based phytomedicines from farm to Bedside.
HIGH IMPACT COLLABORATIONS
FROM FARM TO BEDSIDE: THE WORLD’S PREMIER INTERNATIONAL PHYTOMEDICINES INSTITUTE
June 9, 2019
Dedicated to Research and Education focused on developing Evidence-based phytomedicines for global health and economic development. Leveraging the best science, technology and education from world leading institutions and industry partner institutions to convert potential high impact medicinal plants to evidence-based pharmaceutical grade products for global health and economic development
LAUNCH DURING THE GLOBAL HEALTH CATALYST SUMMIT MAY 26 2019
June 9, 2019
According to the World Health Organization, up to 80% of the populations of developing countries currently use medicinal plants as remedies. Nature has in fact been making biologically active compounds for billions of years. Examples of medicines from plants that have a major impact globally include: morphine from opium Poppy (Papaver somniferum), aspirin from the white willow tree (Salix alba vulgaris), and the anticoagulant coumadin from spoiled sweet clover (Melilotus species). Tropical plants such as the Madagascar Periwinkle (Catharanthus roseus) have yielded vinblastine, which has revolutionized the treatment of Hodgkin's lymphoma, and vincristine, which has done same for acute childhood leukemia.
Recently, over 33 USA states, and a growing number of countries have now legalized medical cannabis. The National Institutes of Health, and World Health Organization encourage research on medical cannabis for treating cancer, the side effects of radiotherapy or chemotherapy and treatment of other diseases incuding pain, neurological disorders and so forth.
Besides Cannabis, it is estimated that of the 300,000 plant species that exist in the world, only 15% have been evaluated to determine their pharmacological potential.
With over a billion people using medicinal plants BUT with little or no scientific evidence, top scientists from Harvard and the world’s best Universities have teamed up and are developing win-win collaborations with phytomedicines industry pioneers and leaders as well as over 800 million stakeholders to generate evidence-based phamaceutical grade products with scientifically established efficacy and toxicity assessment for global health, and economic development
CATALYZING COLLABORATIONS WITH INDUSTRY WORKING WITH THE WORLD'S BEST SCIENTISTS AND ENGINEERS AT LEADING WORLD INSTITUTIONS AND POLICY MAKERS AND STAKEHOLDERS
June 9, 2019
The world’s best scientists and engineers, and largest consortium on phytomedicines targeting over a billion stakeholders using plant medicines across the world
The IPI offers cutting-edge science and education
The world’s best technology
The IPI leverages the best technology and offers smart drug delivery technologies like nanoparticle drones for precise and accurate delivery of phytomedicines payloads,
Precision medicine: Screening drug products for new targets
Medical health professionals are working hand in hand with basic scientists, and bioinformaticians to pinpoint the efficacy of specific drug products in order to develop individually tailored treatment plans. By identifying key genetic alterations, the goal is to personalize approaches to treatment by implementing a combination of therapies.
Artificial Intelligence and cloud-based pharmacies
Bringing the best artificial intelligence to rapidly identify submitted plants, and provide information about these plants, location, medicinal value, any published or documented efficacy and toxicity, predict therapy outcomes, and make recommendations to stakeholders about where and how to secure appropriate products.
Cloud-based pharmacies for dramatic increase in access to evidence-based products
Accelerated Clinical translation
Evidence-based products will be rapidly translated clinically with clinical trials where needed
World class Ivy-league education
Complemetary Course Offerings across the spectrum from Farm to Clinic with certificate, degree programs and continuous education
World class Healthcare team
Best healthcare professionals to make recommendations, develop artificial intelligence on evidence-based products with healthcare provided via partner institutions in collaborating countries across the globe
The Power of Industry collaborations
Outreach Partnerships with pioneering and leading phytomedicines industry leaders in win-win collaborations towards commercialization of developed evidence-based products